Sagimet Biosciences Inc (SGMT)
4.62
-0.13
(-2.74%)
USD |
NASDAQ |
May 17, 16:00
4.62
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences Free Cash Flow: -22.89M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -22.89M |
| December 31, 2023 | -23.77M |
| September 30, 2023 | -24.14M |
| June 30, 2023 | -26.49M |
| Date | Value |
|---|---|
| March 31, 2023 | -26.91M |
| December 31, 2022 | -24.49M |
| September 30, 2022 | -21.94M |
| June 30, 2022 | -18.30M |
Free Cash Flow Range, Past 5 Years
-26.91M
Minimum
Mar 2023
-18.30M
Maximum
Jun 2022
-23.62M
Average
-23.95M
Median
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -391.12M |
| Viking Therapeutics Inc | -54.87M |
| 89bio Inc | -138.82M |
| Arrowhead Pharmaceuticals Inc | -470.16M |
| Akero Therapeutics Inc | -155.88M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.208M |
| Cash from Investing (Quarterly) | 3.00M |
| Cash from Financing (Quarterly) | 104.85M |
| Free Cash Flow Per Share (Quarterly) | -0.2138 |
| Free Cash Flow Yield | -21.47% |